Kanan Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.30 M
- Company Age 26 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 3.50 Cr
- Revenue Growth %
- Profit Growth 22.50%
- Ebitda 22.50%
- Net Worth -0.01%
- Total Assets -0.03%
About Kanan Pharmaceuticals
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230GJ1998PTC034044
-
Company No.
034044
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 May 1998
-
Date of AGM
29 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Kanan Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashok Desai
|
Director | 01-May-1998 | Current |
|
Subhashchandra Desai
|
Director | 01-May-1998 | Current |
|
Jayendra Desai
|
Director | 01-May-1998 | Current |
Financial Performance of Kanan Pharmaceuticals.
Kanan Pharmaceuticals Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 22.5% increase in profit. The company's net worth dipped by a decrease of 0.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kanan Pharmaceuticals?
In 2018, Kanan Pharmaceuticals had a promoter holding of 48.30% and a public holding of 51.70%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Krupa Pharmaceuticals Private LimitedAshok Desai, Subhashchandra Desai and 1 more are mutual person
-
Bhavya Containers Private Limited
Ashok Desai, Subhashchandra Desai and 1 more are mutual person
-
Nectar Medipharma Private Limited
Jayendra Desai is a mutual person
Charges (Loans)
₹0
₹35.00 M
Charges Breakdown by Lending Institutions
- Madhupura Mercantile Co. Op. Bank Ltd. : 3.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 12 May 1999 | Madhupura Mercantile Co. Op. Bank Ltd. | ₹2.50 Cr | Satisfied |
| 30 Jun 1998 | Madhupura Mercantile Co. Op. Bank Ltd. | ₹1.00 Cr | Satisfied |
How Many Employees Work at Kanan Pharmaceuticals?
Unlock and access historical data on people associated with Kanan Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kanan Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kanan Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.